Tatsat Chronicle Magazine

National AYUSH Mission to continue as centrally sponsored scheme till 2026

July 16, 2021
Ayush mission

The Union Cabinet approved the continuation of the National AYUSH Mission (NAM) as a centrally sponsored scheme from April 1, 2021, to March 31, 2026, with the financial implication of Rs. 4607. 30 crore (Rs. 3,000 crore as central share and Rs. 1607.30 crore as state share). The Mission was launched on September 15, 2014.

The National AYUSH Mission (NAM) is expected to give better access to AYUSH healthcare services through increased healthcare facilities offering AYUSH services and better availability of medicines and trained manpower, improvement in AYUSH education through a well-equipped enhanced number of AYUSH educational institutions, and focus on reducing communicable/non-communicable diseases through targeted public health programmes using AYUSH systems of healthcare.

The centrally sponsored scheme of the National AYUSH Mission is being implemented by the Ministry of AYUSH, Government of India with the objectives of providing cost-effective AYUSH services, with universal access through upgrading AYUSH hospitals and dispensaries, co-location of AYUSH facilities at primary health centers (PHCs), community health centers (CHCs) and district hospitals (DHs), strengthening institutional capacity at the state level through upgrading AYUSH educational institutions, setting up of new up to 50 bedded integrated AYUSH Hospital, AYUSH Public Health programmes and operationalization of 12,500 AYUSH health and wellness centres to provide services of a holistic wellness model.

The Mission is addressing the gaps in health services through supporting the efforts of State/UT Governments for providing AYUSH health services/education in the country, particularly in vulnerable and far-flung areas. Under NAM special focus is given for specific needs of such areas and for allocation of higher resources in their Annual Plans.


For , Follow Tatsat Chronicle on FacebookTwitter and get connected to us on LinkedIn